Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000254084 | SCV000314269 | benign | not specified | 2016-03-25 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000725158 | SCV000334550 | uncertain significance | not provided | 2017-07-17 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000725158 | SCV000535732 | likely benign | not provided | 2020-11-18 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 14647208) |
Labcorp Genetics |
RCV001085023 | SCV000559444 | benign | Walker-Warburg congenital muscular dystrophy | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002347967 | SCV002652429 | likely benign | Cardiovascular phenotype | 2019-02-05 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV000725158 | SCV004139818 | likely benign | not provided | 2023-06-01 | criteria provided, single submitter | clinical testing | FKRP: BP4, BP7 |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000254084 | SCV005204816 | likely benign | not specified | 2024-06-17 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001828147 | SCV002088962 | likely benign | Autosomal recessive limb-girdle muscular dystrophy type 2I | 2019-10-24 | no assertion criteria provided | clinical testing |